• InstaBlue Protein Stain Solution for Ferroptosis

  2026-09-14

  Discover how InstaBlue Protein Stain Solution can strengthen protein electrophoresis analysis in hypoxia and ferroptosis studies. This article connects rapid Coomassie Brilliant Blue visualization with mechanistic assay design, orthogonal validation, and mass spectrometry planning.

• Lycorine, ALDH3A1, and Pancreatic Cancer Metabolism

  2026-09-14

  This study combines transcriptomics, molecular docking, and functional validation to identify ALDH3A1-linked fatty acid oxidation as a potential mechanism of lycorine activity in pancreatic cancer. Its findings connect metabolic remodeling with cell-cycle arrest and apoptosis, while also defining important limits for translating the mechanism into therapeutic or assay workflows.

• Propidium Iodide in AMH–SMAD4 Research

  2026-09-13

  A translational framework for using Propidium iodide to connect granulosa-cell membrane integrity, apoptosis, and cell-cycle state with the AMH–SMAD4 mechanism described in a PCOS rat model.

• SETD7 Depletion Drives White Fat Browning in Obesity

  2026-09-12

  The reference study identifies SETD7 as a negative regulator of inguinal white adipose thermogenesis and shows that reducing SETD7 enhances beige-fat formation, energy expenditure, and resistance to diet-induced obesity in mice. Its mechanistic model links SETD7 deficiency to Adcy7, Sirt1, and CREB1 signaling, providing a distinct epigenetic framework for studying adipose browning and metabolic disease.

• Magneto-Piezoelectric Scaffolds for Infectious Bone Repair

  2026-09-11

  This ACS Nano study develops a dual-responsive scaffold that combines magnetic biofilm disruption with ultrasound-triggered metabolic reprogramming of Icam1+ macrophages. Its central mechanistic finding is that activating JAK2-STAT3 while suppressing MAPK-JNK restores oxidative phosphorylation and supports immune-assisted regeneration of infectious bone defects.

• Berbamine Hydrochloride in Ferroptosis Workflows

  2026-09-11

  Use Berbamine hydrochloride as a concentration-controlled perturbation tool to connect STAT3, calcium homeostasis, NF-κB activity, and ferroptosis-related phenotypes. This workflow separates pathway engagement from general cytotoxicity across leukemia cell line KU812 and hepatocellular carcinoma HepG2 cells.

• Recombinant Human EGF for 3D Spheroid Assays

  2026-09-10

  Use recombinant human EGF to tune EGFR-dependent growth conditions while measuring glioblastoma spheroid formation in a compact 96-well workflow. This guide combines product-handling guidance with a recent one-round tumor spheroid method, practical dose finding, and troubleshooting for separating proliferation from stemness.

• Morin Workflows for Oxidative Stress Research

  2026-09-10

  Morin supports complementary workflows for podocyte mitochondrial metabolism, AMPD activity, oxidative-stress biology, and aluminum-ion fluorescence. This practical guide connects assay design, formulation, controls, and troubleshooting while clearly separating bench research from clinical interpretation.

• ECL Chemiluminescent Substrate Detection Kit Workflow

  2026-09-09

  Build a sensitive, flexible western blot workflow for validating low-abundance metabolic and signaling proteins in diabetes research. This guide shows how hypersensitive HRP chemiluminescence, controlled exposure, and membrane-specific optimization can extend data from pathway-focused studies into reproducible immunoblot assays.

• Rosiglitazone in Beige Adipocyte Assay Design

  2026-09-09

  Rosiglitazone (Brl-49653) is more than a PPARγ adipogenesis control: it can help separate adipocyte differentiation from beige thermogenic maturation. This guide translates SEMA3E–β-catenin findings into a practical, mechanistically resolved assay strategy.

• Gemcitabine HCl: From Mechanism to MRI

  2026-09-08

  A translational strategy for connecting Gemcitabine HCl mechanism, cytotoxicity assays, dosing, and multianimal MRI in pancreatic cancer models.

• ECL Chemiluminescent Substrate Detection Kit

  2026-09-08

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced), SKU K1230, is intended for sensitive HRP-based western blot chemiluminescence detection when low-abundance proteins or weak antibody signals are difficult to image. This dossier-based guide covers setup, imaging, quality control, and troubleshooting; it should not be treated as evidence for non-HRP assays or as a substitute for validating quantitative linearity in a specific experiment.

• BMS-777607 Workflows for c-Met Inhibition

  2026-09-07

  BMS-777607 is a potent c-Met inhibitor for dissecting MET-family signaling, metastatic behavior, and kinase-dependent phenotypes. This guide connects validated cancer assays with a clearly bounded exploratory workflow for hiPSC-derived megakaryocyte research.

• Rosiglitazone (Brl-49653): PPARγ Research Guide

  2026-09-07

  Rosiglitazone, also known as Brl-49653, is a synthetic thiazolidinedione PPARγ agonist used to study adipogenesis, glucose handling, and insulin sensitivity modulation. Its strongest research value is mechanistic: it connects PPARγ transcriptional activity with adipocyte biology, while its cancer and vascular findings remain preclinical.

• In Vitro Drug Response: Viability, Death, and Timing

  2026-09-05

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures in cancer drug studies. Its central contribution is a time-aware framework for distinguishing proliferative arrest from actual cell killing, improving interpretation of in vitro response data and the design of follow-up experiments.

8333 records 1/556 page Next 12345 下5页 Last page